Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care: The EFFECT Study: A Randomized Trial
Tu, Jack V.
Donovan, Linda R.
Lee, Douglas S.
Wang, Julie T.
Austin, Peter C.
Alter, David A.
Ko, Dennis T.
JAMA: The Journal of the American Medical Association 2009 December 2; 302(21): 2330-2337
CONTEXT: Publicly released report cards on hospital performance are increasingly common, but whether they are an effective method for improving quality of care remains uncertain. OBJECTIVE: To evaluate whether the public release of data on cardiac quality indicators effectively stimulates hospitals to undertake quality improvement activities that improve health care processes and patient outcomes. DESIGN, SETTING, AND PATIENTS: Population-based cluster randomized trial (Enhanced Feedback for Effective Cardiac Treatment [EFFECT]) of 86 hospital corporations in Ontario, Canada, with patients admitted for acute myocardial infarction (AMI) or congestive heart failure (CHF). INTERVENTION: Participating hospital corporations were randomized to early (January 2004) or delayed (September 2005) feedback of a public report card on their baseline performance (between April 1999 and March 2001) on a set of 12 process-of-care indicators for AMI and 6 for CHF. Follow-up performance data (between April 2004 and March 2005) also were collected. MAIN OUTCOME MEASURES: The coprimary outcomes were composite AMI and CHF indicators based on 12 AMI and 6 CHF process-of-care indicators. Secondary outcomes were the individual process-of-care indicators, a hospital report card impact survey, and all-cause AMI and CHF mortality. RESULTS: The publication of the early feedback hospital report card did not result in a significant systemwide improvement in the early feedback group in either the composite AMI process-of-care indicator (absolute change, 1.5%; 95% confidence interval [CI], -2.2% to 5.1%; P = .43) or the composite CHF process-of-care indicator (absolute change, 0.6%; 95% CI, -4.5% to 5.7%; P = .81). During the follow-up period, the mean 30-day AMI mortality rates were 2.5% lower (95% CI, 0.1% to 4.9%; P = .045) in the early feedback group compared with the delayed feedback group. The hospital mortality rates for CHF were not significantly different. CONCLUSION: Public release of hospital-specific quality indicators did not significantly improve composite process-of-care indicators for AMI or CHF. TRIAL REGISTRATION: http://clinicaltrials.gov Identifier: NCT00187460.
Permanent LinkFind in a Library.
Full Text from Publisher
Showing items related by title, author, creator and subject.
Randomized, Controlled Trial of an Easy-to-Read Informed Consent Statement for Clinical Trial Participation: A Study of the Eastern Cooperative Oncology Group Coyne, Cathy A.; Xu, Ronghui; Raich, Peter; Plomer, Kathy; Dignan, Mark; Wenzel, Lari B.; Fairclough, Diane; Habermann, Thomas; Schnell, Linda; Quella, Susan; Cella, David (2003-03-01)
Who Can Best Recruit to Randomized Trials? Randomized Trial Comparing Surgeons and Nurses Recruiting Patients to a Trial of Treatments for Localized Prostate Cancer (The ProtecT Study) Donovan, Jenny L.; Peters, Tim J.; Noble, Sian; Powell, Philip; Gillatt, David; Oliver, Steven E.; Lane, J. Athene; Neal, David E.; Hamdy, Freddie C. (2003-07)